The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, J.
Right arrow Articles by Young, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, J.
Right arrow Articles by Young, J. W.
The Journal of Immunology, 2006, 176: 2357-2365.
Copyright © 2006 by The American Association of Immunologists

Langerhans-Type Dendritic Cells Genetically Modified to Express Full-Length Antigen Optimally Stimulate CTLs in a CD4-Dependent Manner1

Jianda Yuan*, Jean-Baptiste Latouche2,#, Joanna Hodges,#, Alan N. Houghton{dagger},§,**,{dagger}{dagger}, Glenn Heller||,{dagger}{dagger}, Michel Sadelain,#,**,{dagger}{dagger}, Isabelle Riviere,#,**,{dagger}{dagger} and James W. Young3,*,{ddagger},§,{dagger}{dagger}

* Laboratory of Cellular Immunobiology, {dagger} Laboratory of Tumor Immunology, {ddagger} Allogeneic Blood and Marrow Transplantation and § Clinical Immunology Services, Division of Hematologic Oncology, Department of Medicine, || Biostatistics Service, Department of Biostatistics and Epidemiology, # Laboratory of Gene Transfer and Gene Expression, Gene Transfer and Somatic Cell Engineering Facility, ** Immunology Program, Memorial Sloan-Kettering Cancer Center, and {dagger}{dagger} Weill Medical College of Cornell University, New York, NY 10021

Oncoretroviral vectors encoding either full-length Ag or a corresponding immunodominant peptide were expressed in Langerhans-type dendritic cells (LCs) differentiated from CD34+ progenitors. We used human CMV as a model Ag restricted by HLA-A*0201 to define parameters for eventual expression of cancer Ags by LCs for active immunization against tumors. Stimulation by CMVpp65495–503-pulsed LCs, CMVpp65495–503-transduced LCs, and full-length CMVpp65-transduced LCs respectively increased tetramer-reactive T cells with an effector memory phenotype by 10 ± 11, 34 ± 21, and 51 ± 24-fold (p < 0.05) from CMV-seropositive donors. CMV-specific CD8+ CTLs achieved respective frequencies of 231 ± 102, 583 ± 219, and 714 ± 281 spot-forming cells per 105 input cells (p < 0.01) in ELISPOT assays for IFN-{gamma} secretion. LCs expressing full-length Ag stimulated greater lytic activity than either peptide-transduced or peptide-pulsed LCs (p < 0.05), all in the absence of exogenous cytokines. pp65-transduced LCs presenting class I and II MHC-restricted epitopes expanded IFN-{gamma}-secreting CD4+ T cells, whereas pp65495–503-transduced LCs did not. CD4+ T cell numbers even declined after stimulation by pp65495–503 peptide-pulsed LCs. CD4+ T cell depletion confirmed their contribution to the more robust CTL responses. LCs, transduced with a retroviral vector encoding full-length Ag, stimulate potent CTLs directed against multiple epitopes in a CD4+ Th cell-dependent manner.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.